Blood Culture Tests Market Analysis by Application (Bacteremia, Fungaemia, and Mycobacterial Detection); and by End User (Hospital, and Academic Research) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 4851 | Published Date: Apr 28, 2023
Blood Culture Tests Market size is estimated to garner a revenue of ~USD 22 billion by the end of 2035 by growing at a CAGR of ~11.90% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 6 billion in the year 2023. The market growth is mainly owing to the increasing prevalence of sepsis and other blood infections, the growing demand for rapid and accurate diagnostic tests, and the development of advanced technologies for blood culture testing. In addition, the rise in healthcare expenditure and the increasing awareness of the importance of early detection and treatment of blood infections are also contributing to the growth of the blood culture tests market. According to the World Health Organization (WHO), sepsis is estimated to affect over 30 million people worldwide every year, and it is responsible for more than six million deaths annually.
In addition to this, in the United States, sepsis is a major cause of hospitalizations, with over 1.7 million cases reported annually, according to the Centers for Disease Control and Prevention (CDC). Sepsis is also a leading cause of death in hospitals, with over 270,000 deaths reported annually in the US. The prevalence of sepsis is increasing globally, driven by several factors such as an aging population, the increasing number of patients with chronic diseases, and the rise in antibiotic-resistant infections. In addition, the COVID-19 pandemic has also contributed to an increase in sepsis cases, as many patients with severe COVID-19 infections develop sepsis as a complication. Early diagnosis and prompt treatment are critical for improving outcomes in sepsis patients. This has led to a growing demand for rapid and accurate diagnostic tests, such as blood culture tests, which can help identify the pathogen causing the infection and guide appropriate treatment.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~11.90% |
|
Base Year Market Size (2023) |
~ USD 6 Billion |
|
Forecast Year Market Size (2035) |
~ USD 22 Billion |
|
Regional Scope |
|
Growth Drivers
Challenges
The blood culture tests market is segmented and analyzed for demand and supply by end users into hospital, and academic research. Out of the two types of end users, the hospital segment is estimated to gain the largest market share of about ~60% in the year 2035. The growth of the segment can be accredited to the large number of patients requiring treatment for various conditions. The hospitals are also growing rapidly in number, which is estimated to positively influence segmental growth. For instance, by the year 2022, there were noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology. By definition of a hospital, a county hospital is typically a primary medical facility in a region with numerous intensive care and mobile beds for patients requiring long-term care.
The global blood culture tests market is also segmented and analyzed for demand and supply by applications into bacteraemia, fungaemia, and mycobacterial detection. Amongst these three segments, the bacteraemia segment is expected to garner a significant share of around ~30% in the year 2035. The growth of the segment can be accredited to the increasing prevalence of bacterial infections. Bacterial infections, including bacteraemia, are a significant global health problem. According to a study published in the journal Lancet Infectious Diseases, sepsis, which often presents with bacteraemia, affects over 30 million people worldwide each year. This high prevalence of bacterial infections is driving the demand for blood culture tests for early diagnosis and treatment. There is an increasing awareness of sepsis and its symptoms among healthcare workers and the general public, which has led to increased use of blood culture tests for the diagnosis of sepsis. Technological advancements in blood culture testing, such as the introduction of automated blood culture systems and the development of new blood culture media, have improved the accuracy and speed of blood culture testing for the detection of bacteraemia. The demand for point-of-care testing for the rapid diagnosis of bacteraemia is increasing, particularly in emergency departments and intensive care units. Point-of-care blood culture testing can provide results in hours, compared to several days for conventional blood culture testing, and can help guide the selection of appropriate antibiotics.
Our in-depth analysis of the global blood culture tests market includes the following segments:
|
By End User |
|
|
By Application
|
|
Blood culture tests market in the Asia Pacific region, amongst the market in all the other regions, are projected to hold the largest market share of about ~35% by the end of 2035. The regional growth can majorly be attributed to the increasing prevalence of infectious diseases. The Asia Pacific region has a high burden of infectious diseases, including bacterial infections that can lead to sepsis and bacteremia. According to a study, the prevalence of bloodstream infections in the Asia Pacific region ranges from 15-27% in different patient populations. This high prevalence is expected to drive the demand for blood culture tests in the region. Many countries in the Asia Pacific region are investing in improving their healthcare infrastructure, including laboratory facilities for the diagnosis of infectious diseases. For instance, the Indian government has launched the National Health Mission, which aims to improve healthcare access and infrastructure in the country. This investment is expected to drive the demand for blood culture tests in the region. There is increasing awareness of sepsis and its symptoms among healthcare workers and the general public in the Asia Pacific region. The demand for point-of-care testing for the rapid diagnosis of bacteraemia is increasing in the Asia Pacific region, particularly in rural and remote areas where access to laboratory facilities is limited. Point-of-care blood culture testing can provide results in hours, compared to several days for conventional blood culture testing, and can help guide the selection of appropriate antibiotics.
The blood culture tests market in the North America region, amongst the in all the other regions, is projected to hold the second largest share of about ~24% during the forecast period. The growth of the market in this region can primarily be attributed to the technological advancements in blood culture testing. North America is a leading region in terms of technological advancements in blood culture testing. Automated blood culture systems, rapid diagnostic tests, and molecular diagnostics are widely used in the region for the diagnosis of bloodstream infections. These advancements have improved the accuracy and speed of blood culture testing, which is expected to drive the demand for these tests in the region. The demand for point-of-care testing for the rapid diagnosis of bacteraemia is increasing in North America, particularly in emergency departments and intensive care units. Point-of-care blood culture testing can provide results in hours, compared to several days for conventional blood culture testing, and can help guide the selection of appropriate antibiotics. North America has a strong regulatory framework for medical devices, including blood culture tests. The US Food and Drug Administration (FDA) and Health Canada are responsible for regulating the safety and efficacy of medical devices, including blood culture tests. This strong regulatory framework ensures that blood culture tests meet the required standards for accuracy and reliability, which is expected to drive the demand for these tests in the region.
Further, the blood culture tests market in the Europe region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing incidence of antimicrobial resistance. The growing problem of antimicrobial resistance is driving the demand for blood culture tests for the identification of antibiotic-resistant bacteria. Blood culture tests can help identify the specific type of bacteria causing the infection and guide the selection of appropriate antibiotics, thereby reducing the risk of antimicrobial resistance. The demand for point-of-care testing for the rapid diagnosis of bacteraemia is increasing in Europe, particularly in emergency departments and intensive care units. Point-of-care blood culture testing can provide results in hours, compared to several days for conventional blood culture testing, and can help guide the selection of appropriate antibiotics. Europe has a strong regulatory framework for medical devices, including blood culture tests. The European Medicines Agency (EMA) is responsible for regulating the safety and efficacy of medical devices, including blood culture tests. This strong regulatory framework ensures that blood culture tests meet the required standards for accuracy and reliability, which is expected to drive the demand for these tests in the region.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing prevalence of sepsis and other blood infections are the major factors driving the market growth.
Ans: The market size of blood culture tests is anticipated to attain a CAGR of ~11.90% over the forecast period, i.e., 2023 – 2035.
Ans: The limited Sensitivity of Blood Culture Testing is estimated to be the growth hindering factor for the market expansion.
Ans: The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Luminex Corporation, Danaher Corporation, Abbott Laboratories, Roche Diagnostics International Ltd., Cepheid Inc., T2 Biosystems, Inc., and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by application, end-user, and by region.
Ans: The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
